Hypertension is a prevalent chronic condition with a sizable patient population and suboptimal blood pressure control rates, resulting in a substantial economic burden on individuals and society. Strengthening health management strategies for hypertensive patients is a crucial intervention to improve blood pressure control. Although standardized hypertension management has been widely implemented in primary care settings, existing studies indicate that blood pressure control rates in China remain unsatisfactory. This paper examines research did in China on the effectiveness of blood pressure control and the factors influencing it among hypertensive patients receiving standardized management. Several limitations in the current body of research are identified, including a paucity of high-quality studies, narrow research scope in terms of influencing factors, inconsistent selection of blood pressure metrics, varied approaches to evaluating long-term blood pressure management, and non-alignment of target blood pressure definitions with international guidelines. The paper proposes future research recommendations, such as standardizing blood pressure control criteria, expanding the study of patients under standardized management, broadening research perspectives to explore the impact of multilevel determinants on blood pressure control, and leveraging big data and artificial intelligence technologies to advance precision management for hypertensive patients.
